Close Icon

Database Lock in a Day


With AI, you can go from LPO to database lock in 24 hours or less.​


Saama has accelerated over 1,500 clinical trials using advanced analytics, AI, and automation. Thanks to our technology, the clinical trial data for Pfizer’s COVID-19 vaccine was ready for review just 22 hours after meeting primary efficacy case counts–a time savings of more than a month.

Put us to the test: Learn how you can achieve database lock in as little as a day!

Saama applies analytics, automation, and AI to accelerate your clinical trials.

COVID-19 was a wakeup call for clinical trial sponsors worldwide: manual processes and outdated ways of doing things just don’t cut it anymore. Saama’s world-renowned Life Science Analytics Cloud (LSAC) puts real intelligence into drug discovery and development by streamlining workflows, improving performance, and getting life-changing medical treatments to patients faster.

Embrace the inevitable change with Saama’s Database Lock in a Day Guarantee*

If you’ve stayed with us this far, you must be intrigued by the idea of transforming your clinical trial processes. We’re going to make it fun, exciting, and easy for you. We’ve accelerated more than 1,500 clinical trials over the years, and we’re confident we can get you from LPO to database lock in as little as 24 hours or less. To speak to someone regarding the guarantee, just complete the form. You must be a pharmaceutical company, nonprofit organization, government agency, or CRO that regularly sponsors and/or manages clinical trials.

* Subject to additional terms and conditions set forth in written agreement between the parties.

To see if you qualify, just complete the form below:

Terms & Conditions

By inquiring about Saama’s Database Lock in a Day, you agree to be contacted by Saama and to allow Saama to use, maintain, store, and protect your personal data in accordance with our Privacy Policy.

Eligibility details are for informational purposes only. Saama, in its sole discretion, will determine your eligibility based on the information you disclose as part of the intake process. If Saama determines that you are eligible to participate, you will be notified by separate email. Eligibility depends on certain criteria, such as the size of your company, the types of clinical trials you sponsor, and the number of patients in–and stages of–your current clinical trials.

By completing the request form, you represent that you have authority to proceed on behalf of your company. Should you agree to participate, you agree to reasonably cooperate with Saama in following the guidelines and procedures required for integrating, standardizing, and analyzing your data. Participation requires the use of our Smart Data Quality application, a technology-agnostic AI engine that sits on top of your current infrastructure. The application can be used immediately, and you’re only charged for the services you use based on a predetermined estimate.

Information you share with Saama during your participation may be anonymized and/or aggregated, and made available publicly in Saama marketing materials. This information may include: types of systems and processes involved, types of departments involved, and size and regional location of your company. Such information will never be directly associated with you, nor will you or your company be identifiable without express written permission.